Trial Profile
Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 27 Mar 2010 Actual patient number (31) added as reported by ClinicalTrials.gov.
- 27 Mar 2010 Actual end date (March 2010) added as reported by ClinicalTrials.gov.
- 27 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.